Abstract
In Australia, a patent may be granted for a new therapeutic use of a known drug, or for new dosage regimes or administrations of known drugs. This article looks at three recent cases where the Federal Court considered what amounts to infringement of these patents. They are infringed only if the medication is prescribed or supplied for the new therapeutic purpose (a new indication), and not if they are prescribed to treat some other condition.
| Original language | English |
|---|---|
| Pages (from-to) | 187-190 |
| Number of pages | 4 |
| Journal | Australian Intellectual Property Law Bulletin |
| Volume | 25 |
| Issue number | 9 |
| Publication status | Published - 2013 |